{
    "url_original": "https://www.wsj.com/articles/biogen-shareholders-face-the-waiting-game-11634741098?mod=business_minor_pos10",
    "url": "biogen-shareholders-face-the-waiting-game-11634741098",
    "title": "Biogen Shareholders Face the Waiting Game",
    "sub_head": "Investor enthusiasm for Biogen won’t come back until key questions about its new Alzheimer’s disease drug are resolved",
    "category_1": "Markets",
    "category_2": "Heard on the Street",
    "image_1_url": "https://images.wsj.net/im-419583?width=860&height=573",
    "image_1": "im-419583.jpg",
    "time": "2021-10-20 16:22:00"
}